GlaxoSmithKline announced that its once-weekly diabetes drug called albiglutide was effective in late-stage clinical trials.
A story in Reuters about the announcement speculates that despite those results, the drug may face challenges in an increasingly competitive market for diabetes drugs. But some of the newer types of diabetes drugs such as Januvia and Byetta have generated health concerns recently.
The medical journal BMJ has published an investigation about the diabetes drugs called ...
continue reading...
In a study published in Annals of Internal Medicine, Canadian researchers are advising doctors to avoid ordering certain antibiotics for patients taking the cholesterol-lowering drugs known as statins, which include Lipitor.
According to a report on WEWS-TV out of Cleveland, patients who filed lawsuits over the Mirena intrauterine device are reporting a
A judge recently ordered Johnson & Johnson’s Ethicon division to pay Irish health care products manufacturer Covidien $176.5 million in damages over a patent dispute, Bloomberg reports.
The U.S. Food and Drug Administration has approved Johnson & Johnson’s drug Invokana, which will be used to treat type 2 diabetes.
